First JAK Inhibitor Approved by FDA for Treatment of Crohn’s

Posted by Michael Jannicelli | Sep 25, 2023 | Uncategorized | 0 |

Rinvoq:

www.medpagetoday.com

First JAK Inhibitor Approved for Crohn’s Disease

Upadacitinib lands indication for moderately to severely active disease in adults

www.medpagetoday.com

A new class of drugs for Crohn’s and thus new treatment options. Due to increased risk of blood clots and cancer, use of Rinvoq is to restricted those Crohn’s patients who have already flunked therapy with…

First JAK Inhibitor Approved by FDA for Treatment of Crohn’s

About The Author

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.